Equity Residential EQR
We take great care to ensure that the data presented and summarized in this overview for EQUITY RESIDENTIAL is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EQR
View all-
Vanguard Group Inc Valley Forge, PA57MShares$3.83 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY40.1MShares$2.69 Billion0.06% of portfolio
-
State Street Corp Boston, MA23.7MShares$1.59 Billion0.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD20.3MShares$1.36 Billion0.16% of portfolio
-
Apg Asset Management Us Inc. New York, NY11.6MShares$779 Million4.23% of portfolio
-
Jpmorgan Chase & CO New York, NY9.45MShares$634 Million0.05% of portfolio
-
First Eagle Investment Management, LLC9.34MShares$627 Million1.35% of portfolio
-
Geode Capital Management, LLC Boston, MA8.64MShares$580 Million0.05% of portfolio
-
Resolution Capital LTD Sydney, Nsw, C37.59MShares$509 Million8.56% of portfolio
-
D1 Capital Partners L.P. New York, NY6.93MShares$465 Million8.33% of portfolio
Latest Institutional Activity in EQR
Top Purchases
Top Sells
About EQR
Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.
Insider Transactions at EQR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 14
2024
|
Ian Kaufman Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.13%
|
$1,643
$53.71 P/Share
|
Apr 26
2024
|
Mary Kay Haben Director |
SELL
Open market or private sale
|
Direct |
3,241
-25.01%
|
$210,665
$65.48 P/Share
|
Apr 26
2024
|
Mary Kay Haben Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,241
+20.0%
|
$168,532
$52.2 P/Share
|
Apr 24
2024
|
Alexander Brackenridge Executive Vice President & CIO |
SELL
Open market or private sale
|
Direct |
4,027
-5.45%
|
$261,755
$65.01 P/Share
|
Mar 19
2024
|
Nina P Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
784
+50.0%
|
-
|
Mar 19
2024
|
Ann Hoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
588
+50.0%
|
-
|
Feb 28
2024
|
Stephen E Sterrett Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,976
+9.35%
|
$98,800
$50.6 P/Share
|
Feb 28
2024
|
John E Neal Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,976
+8.97%
|
$98,800
$50.6 P/Share
|
Feb 28
2024
|
Mark S Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,976
+10.23%
|
$98,800
$50.6 P/Share
|
Feb 28
2024
|
Ian Kaufman Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150
+0.62%
|
$7,500
$50.6 P/Share
|
Feb 28
2024
|
Barry Altshuler Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
1,976
+4.23%
|
$98,800
$50.6 P/Share
|
Feb 13
2024
|
Ian Kaufman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
716
-2.9%
|
$40,812
$57.8 P/Share
|
Feb 13
2024
|
Scott Fenster EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
829
-2.28%
|
$47,253
$57.8 P/Share
|
Feb 13
2024
|
Robert Garechana EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
876
-4.02%
|
$49,932
$57.8 P/Share
|
Feb 13
2024
|
Catherine Carraway EVP & CHRO |
SELL
Open market or private sale
|
Direct |
291
-2.49%
|
$16,587
$57.8 P/Share
|
Feb 05
2024
|
Michael L Manelis Executive Vice President & COO |
SELL
Open market or private sale
|
Direct |
1,639
-5.01%
|
$96,701
$59.43 P/Share
|
Feb 05
2024
|
Catherine Carraway EVP & CHRO |
SELL
Open market or private sale
|
Direct |
49
-0.39%
|
$2,891
$59.43 P/Share
|
Feb 01
2024
|
Michael L Manelis Executive Vice President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
6,076
+15.67%
|
-
|
Feb 01
2024
|
Ian Kaufman Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,660
+15.89%
|
-
|
Feb 01
2024
|
Scott Fenster EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
9,264
+20.34%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 77.8K shares |
---|---|
Exercise of conversion of derivative security | 147K shares |
Open market or private sale | 151K shares |
---|